CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 113 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,185 | -23.7% | 145,910 | +11.1% | 0.00% | -33.3% |
Q2 2023 | $4,175 | -71.5% | 131,342 | -78.1% | 0.00% | -57.1% |
Q1 2023 | $14,660 | +1.8% | 601,054 | +31.6% | 0.01% | +16.7% |
Q4 2022 | $14,402 | -99.5% | 456,615 | +367.2% | 0.01% | +100.0% |
Q3 2022 | $2,762,000 | +3632.4% | 97,735 | +3371.9% | 0.00% | – |
Q2 2022 | $74,000 | -69.0% | 2,815 | -58.7% | 0.00% | – |
Q1 2022 | $239,000 | – | 6,817 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,005,284,000 | 38.09% |
Ally Bridge Group (NY) LLC | 1,767,440 | $29,304,000 | 5.02% |
Affinity Asset Advisors, LLC | 270,000 | $4,477,000 | 2.37% |
SPHERA FUNDS MANAGEMENT LTD. | 811,665 | $13,457,000 | 1.19% |
Artal Group S.A. | 2,282,100 | $37,837,000 | 0.81% |
Perceptive Advisors | 4,544,062 | $75,340,000 | 0.81% |
RA Capital Management | 2,200,000 | $36,476,000 | 0.51% |
Monashee Investment Management LLC | 200,000 | $3,316,000 | 0.44% |
Boxer Capital, LLC | 714,500 | $11,846,000 | 0.38% |
EcoR1 Capital, LLC | 400,000 | $6,632,000 | 0.36% |